Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, 388-1, Poongnap 2-dong, Songpa-gu, Seoul, 138-736, Republic of Korea.
AJR Am J Roentgenol. 2012 Dec;199(6):1380-6. doi: 10.2214/AJR.10.6306.
The purpose of this study was to evaluate the clinical effectiveness of polytetrafluoroethylene (PTFE)-covered retrievable expandable nitinol stents in patients with malignant esophageal strictures and to identify prognostic factors associated with clinical outcomes.
From 2001 to 2010, 320 PTFE-covered stents were placed in 270 patients. Technical and clinical success, complications, survival, and stent patency were measures of clinical effectiveness. The relationships among complications and age, sex, stricture location, stricture length, chemotherapy alone, chemoradiotherapy, and malignancy source were examined. Independent prognostic factors of overall survival and stent patency were identified.
Stent placement and removal were technically successful and tolerated without procedural complications, and 98% of patients achieved clinical success. The complication rate was 30%. Two removed stents exhibited covering membrane separation. Chemotherapy was associated with increased stent migration (p = 0.002). Stricture location and chemoradiotherapy were associated with esophagorespiratory fistula development (p = 0.033 and p < 0.001, respectively). Median and mean survival periods were 114 days (95% CI, 102-126 days) and 166 days (138-193 days). Chemotherapy and chemoradiotherapy were independent prognostic factors for survival (p = 0.050 and p = 0.032, respectively). The median and mean stent patency periods were 60 days (41-79 days) and 90 days (71-108 days). Chemoradiotherapy was the only independent prognostic factor for stent patency (p = 0.012).
The PTFE-covered stents were clinically effective. Membrane degradation was not evident, although 0.7% of the patients experienced covering membrane separation. Chemotherapy was associated with increased migration and prolonged survival. Chemoradiotherapy was associated with increased esophagorespiratory fistula formation and decreased stent patency.
本研究旨在评估聚四氟乙烯(PTFE)覆膜可回收扩张镍钛诺支架治疗恶性食管狭窄的临床疗效,并确定与临床结果相关的预后因素。
2001 年至 2010 年,270 例患者共置入 320 枚 PTFE 覆膜支架。技术和临床成功率、并发症、生存率和支架通畅率是临床疗效的衡量指标。分析了并发症与年龄、性别、狭窄部位、狭窄长度、单纯化疗、放化疗以及恶性肿瘤来源之间的关系。确定了总生存率和支架通畅率的独立预后因素。
支架置入和取出均技术成功,无操作相关并发症,98%的患者获得临床成功。并发症发生率为 30%。2 枚取出的支架出现覆盖膜分离。化疗与支架迁移增加相关(p = 0.002)。狭窄部位和放化疗与食管-呼吸道瘘的发生相关(p = 0.033 和 p < 0.001)。中位和平均生存时间分别为 114 天(95%CI,102-126 天)和 166 天(138-193 天)。化疗和放化疗是生存的独立预后因素(p = 0.050 和 p = 0.032)。中位和平均支架通畅时间分别为 60 天(41-79 天)和 90 天(71-108 天)。放化疗是支架通畅的唯一独立预后因素(p = 0.012)。
PTFE 覆膜支架具有临床疗效。尽管有 0.7%的患者出现覆盖膜分离,但未发现膜降解。化疗与迁移增加和生存延长相关。放化疗与食管-呼吸道瘘形成增加和支架通畅率降低相关。